Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kosmidis, Mary H
Breier, Alan
and
Fantie, Bryan D
1999.
Avoidance learning in schizophrenia: a dissociation between the effects of aversive and non-aversive stimuli.
Schizophrenia Research,
Vol. 38,
Issue. 1,
p.
51.
Swainson, R.
Rogers, R.D.
Sahakian, B.J.
Summers, B.A.
Polkey, C.E.
and
Robbins, T.W.
2000.
Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.
Neuropsychologia,
Vol. 38,
Issue. 5,
p.
596.
Robbins, T. W.
and
Everitt, B. J.
2002.
Dopamine in the CNS II.
Vol. 154 / 2,
Issue. ,
p.
173.
Wickens, Jeffery R
Reynolds, John NJ
and
Hyland, Brian I
2003.
Neural mechanisms of reward-related motor learning.
Current Opinion in Neurobiology,
Vol. 13,
Issue. 6,
p.
685.
Beninger, Richard J.
Wasserman, James
Zanibbi, Katherine
Charbonneau, Danielle
Mangels, Jennifer
and
Beninger, Bruce V.
2003.
Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.
Schizophrenia Research,
Vol. 61,
Issue. 2-3,
p.
281.
2004.
Human Brain Function.
p.
445.
Schmidt, Werner J.
2005.
Dopamine and Glutamate in Psychiatric Disorders.
p.
523.
Robbins, T.W.
2005.
Dopamine.
Vol. 21,
Issue. ,
p.
395.
Perretta, James G
Pari, Giovanna
and
Beninger, Richard J
2005.
Effects of Parkinson Disease on Two Putative Nondeclarative Learning Tasks.
Cognitive and Behavioral Neurology,
Vol. 18,
Issue. 4,
p.
185.
Bokura, Hirokazu
Yamaguchi, Shuhei
and
Kobayashi, Shotai
2005.
Event-related potentials for response inhibition in Parkinson's disease.
Neuropsychologia,
Vol. 43,
Issue. 6,
p.
967.
Beninger, Richard J.
2006.
Dopamine and incentive learning: A framework for considering antipsychotic medication effects.
Neurotoxicity Research,
Vol. 10,
Issue. 3-4,
p.
199.
Frank, Michael J.
and
O'Reilly, Randall C.
2006.
A mechanistic account of striatal dopamine function in human cognition: Psychopharmacological studies with cabergoline and haloperidol..
Behavioral Neuroscience,
Vol. 120,
Issue. 3,
p.
497.
Cools, Roshan
2006.
Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease.
Neuroscience & Biobehavioral Reviews,
Vol. 30,
Issue. 1,
p.
1.
Frank, Michael J.
2006.
Hold your horses: A dynamic computational role for the subthalamic nucleus in decision making.
Neural Networks,
Vol. 19,
Issue. 8,
p.
1120.
Paelecke-Habermann, Yvonne
Ebersbach, Georg
and
Leplow, Bernd
2007.
Depressivität und Depression bei der Parkinson-Erkrankung.
Zeitschrift für Neuropsychologie,
Vol. 18,
Issue. 3,
p.
207.
Moustafa, Ahmed A.
Sherman, Scott J.
and
Frank, Michael J.
2008.
A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
Neuropsychologia,
Vol. 46,
Issue. 13,
p.
3144.
Voon, Valerie
Fernagut, Pierre-Olivier
Wickens, Jeff
Baunez, Christelle
Rodriguez, Manuel
Pavon, Nancy
Juncos, Jorge L
Obeso, José A
and
Bezard, Erwan
2009.
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
The Lancet Neurology,
Vol. 8,
Issue. 12,
p.
1140.
Wickens, Jeffery R.
2009.
Synaptic plasticity in the basal ganglia.
Behavioural Brain Research,
Vol. 199,
Issue. 1,
p.
119.
Price, Amanda
Filoteo, J. Vincent
and
Maddox, W. Todd
2009.
Rule-based category learning in patients with Parkinson's disease.
Neuropsychologia,
Vol. 47,
Issue. 5,
p.
1213.
Wasserman, James I.
Barry, Rebecca J.
Bradford, Lisa
Delva, Nicholas J.
and
Beninger, Richard J.
2012.
Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics.
Psychopharmacology,
Vol. 222,
Issue. 1,
p.
173.